시장보고서
상품코드
1147468

미생물 발효 기술 시장 규모, 점유율, 동향 분석 리포트 : 응용별(항생제, 백신), 최종 응용별(바이오 제약회사), 지역별, 부문별 예측(2022-2030년)

Microbial Fermentation Technology Market Size, Share & Trends Analysis Report By Application (Antibiotics, Vaccines), By End-use (Biopharmaceutical Companies), By Region, And Segment Forecasts, 2022 - 2030

발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 170 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Grand View Research, Inc.의 최신 보고서에 따르면 미생물 발효 기술 세계 시장 규모는 2030년까지 494억 달러에 이를 것으로 예측됩니다. 이 시장은 2022년부터 2030년까지 연평균 복합 성장률(CAGR) 6.0%로 확대될 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

  • 조사의 전제조건
  • 조사 방법
  • 정보 조달
    • 미생물 발효 기술 시장에 관한 조사 샘플 사이즈
      • 1차 정보
      • 2차 데이터 소스
  • 정보 또는 데이터 분석
  • 시장 형성 및 검증
  • 세계 시장 : CAGR 계산
  • 대상

제2장 개요

  • 시장 개요, 2021년
  • 시장 세분화
  • 경쟁 환경

제3장 시장 변수, 동향 및 범위

  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 2021년 응용 침투 및 성장 전망 매핑(100만 달러)
  • COVID-19의 영향 분석
  • 사업 환경 분석
    • SWOT 분석 : 요인별(정치, 법률, 경제, 기술)
    • Porter's Five Forces 분석

제4장 미생물 발효 기술 시장 : 응용 비즈니스 분석

  • 미생물 발효 기술 시장 : 응용 변동 분석
  • 항생제
  • 프로바이오틱스 보충제
  • 단클론항체
  • 재조합 단백질
  • 바이오시밀러
  • 백신
  • 효소
  • 소분자
  • 기타

제5장 미생물 발효 기술 시장 : 최종사용자 비즈니스 분석

  • 미생물 발효 기술 시장 : 최종사용자 변동 분석
  • 바이오의약품 기업
  • 수탁연구기관(CRO)
  • CMO &CDMO
  • 학술기관/연구기관

제6장 미생물 발효 기술 시장 : 지역 비즈니스 분석

  • 미생물 발효 기술 시장 : 지역 변동 분석
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 스페인
    • 이탈리아
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 중동 및 아프리카(MEA)
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)

제7장 기업 개요

  • 기업 개요
    • BIOCON LTD.
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • BIOVECTRA INC.
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • DANONE UK
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • F. HOFFMANN-LA ROCHE LTD
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • KONINKLIJKE DSM NV
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • LONZA
      • 기업 개요
      • 폴 주식회사
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • NOVOZYMES A/S
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • TERRAVIA HOLDINGS, INC.
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
      • 전략적 이니셔티브
    • BIOZEEN
      • 기업 개요
      • 재무 실적
      • 제품 벤치마킹
LSH 22.11.17

Microbial Fermentation Technology Market Growth & Trends:

The global microbial fermentation technology market size is expected to reach USD 49.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2022 to 2030. Since fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing. This has led to increasing collaborations and developments in this market space.

For instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA's manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale. Moreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.

Furthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.

Additionally,various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates. This gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.

Microbial Fermentation Technology Market Report Highlights:

  • Based on application, the antibiotics segment captured the highest market revenue share in 2021. Increasing research activities due to the rise of antibiotic-resistant microbes have positively impacted market growth
  • Owing to the faster and stable growth pattern of microorganisms, the use of fermentation in small molecule synthesis is expected to witness a lucrative growth throughout the forecast period
  • By end-users, CMOs and CDMOs accounted for a significant share in 2021. The capacity expansion by several CMOs and the growing trend of outsourcing are expected to propel the segment revenue generation
  • Asia Pacific dominated the market in 2021 owing to the high number of operating CMOs and growing biopharmaceutical industry in countries such as India, Japan, and China
  • Furthermore, the demand for biologics and biopharmaceuticals is increasing in Japan. As a result, Japanese firms are undertaking various strategic initiatives to enhance their domestic biomanufacturing operations
  • North America is anticipated to witness the fastest growth throughout the forecast period owing to the presence of a well-established biopharmaceutical industry coupled with a high number of fermentation solution providers
  • Continuous efforts by key players to improve their product offerings are also contributing to North America's regional market growth

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Assumptions
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Sample size for the study on microbial fermentation technology market:
      • 1.3.1.1 Primary Sources
      • 1.3.1.2 Secondary Data Sources
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation & Validation
  • 1.6 Global Market: CAGR Calculation
  • 1.7 Objectives
    • 1.7.1 Objective 1
    • 1.7.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Summary, 2021
  • 2.2 Market Segmentation
  • 2.3 Competitive Milieu

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing usage of fermentation technology-derived products among various industries
      • 3.1.1.2 Rising research and development activities in different fields of fermentation technology
      • 3.1.1.3 Exhausting fossil fuel reserves and rising gasoline prices
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Technological challenges associated with microbial fermentation
  • 3.2 Penetration and Growth Prospect Mapping for Application, 2021 (USD Million)
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Business Environment Analysis
    • 3.4.1 SWOT analysis; by factor (political & legal, economic, and technological)
    • 3.4.2 Porter's five forces analysis

Chapter 4 Microbial Fermentation Technology Market: Application Business Analysis

  • 4.1 Microbial Fermentation Technology Market: Application Movement Analysis
  • 4.2 Antibiotics
    • 4.2.1 Global antibiotics market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3 Probiotics Supplements
    • 4.3.1 Global probiotic supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4 Monoclonal Antibodies
    • 4.4.1 Global monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5 Recombinant Proteins
    • 4.5.1 Global recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6 Biosimilars
    • 4.6.1 Global biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7 Vaccines
    • 4.7.1 Global vaccines market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.8 Enzymes
    • 4.8.1 Global enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.9 Small Molecules
    • 4.9.1 Global small molecules market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.10 Others
    • 4.10.1 Global other applications market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Microbial Fermentation Technology Market: End-User Business Analysis

  • 5.1 Microbial Fermentation Technology Market: End-user Movement Analysis
  • 5.2 Biopharmaceutical Companies
    • 5.2.1 Microbial fermentation technology market for biopharmaceutical companies, 2018 - 2030 (USD Million)
  • 5.3 Contract Research Organizations (CROs)
    • 5.3.1 Microbial fermentation technology market for contract research organizations, 2018 - 2030 (USD Million)
  • 5.4 CMOs & CDMOs
    • 5.4.1 Microbial fermentation technology market for CMOs & CDMOs, 2018 - 2030 (USD Million)
  • 5.5 Academic & Research Institutes
    • 5.5.1 Microbial fermentation technology market for academic & research institutes, 2018 - 2030 (USD Million)

Chapter 6 Microbial Fermentation Technology Market: Regional Business Analysis

  • 6.1 Microbial Fermentation Technology Market: Regional Movement Analysis
  • 6.2 North America
    • 6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Germany
      • 6.3.2.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3 U.K.
      • 6.3.3.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5 Spain
      • 6.3.5.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.3 India
      • 6.4.3.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.4 Japan
      • 6.4.4.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 Middle East Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Company Profiles
    • 7.1.1 BIOCON LTD.
      • 7.1.1.1 Company overview
      • 7.1.1.2 Financial performance
      • 7.1.1.3 Product benchmarking
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 BIOVECTRA INC.
      • 7.1.2.1 Company overview
      • 7.1.2.2 Financial performance
      • 7.1.2.3 Product benchmarking
      • 7.1.2.4 Strategic initiatives
    • 7.1.3 DANONE UK
      • 7.1.3.1 Company overview
      • 7.1.3.2 Financial performance
      • 7.1.3.3 Product benchmarking
      • 7.1.3.4 Strategic initiatives
    • 7.1.4 F. HOFFMANN-LA ROCHE LTD
      • 7.1.4.1 Company overview
      • 7.1.4.2 Financial performance
      • 7.1.4.3 Product benchmarking
      • 7.1.4.4 Strategic initiatives
    • 7.1.5 KONINKLIJKE DSM NV
      • 7.1.5.1 Company overview
      • 7.1.5.2 Financial performance
      • 7.1.5.3 Product benchmarking
      • 7.1.5.4 Strategic initiatives
    • 7.1.6 LONZA
      • 7.1.6.1 Company overview
      • 7.1.6.2 Pall Corporation
      • 7.1.6.3 Financial performance
      • 7.1.6.4 Product benchmarking
      • 7.1.6.5 Strategic initiatives
    • 7.1.7 NOVOZYMES A/S
      • 7.1.7.1 Company overview
      • 7.1.7.2 Financial performance
      • 7.1.7.3 Product benchmarking
      • 7.1.7.4 Strategic initiatives
    • 7.1.8 TERRAVIA HOLDINGS, INC.
      • 7.1.8.1 Company overview
      • 7.1.8.2 Financial performance
      • 7.1.8.3 Product benchmarking
      • 7.1.8.4 Strategic initiatives
    • 7.1.9 BIOZEEN
      • 7.1.9.1 Company overview
      • 7.1.9.2 Financial performance
      • 7.1.9.3 Product benchmarking
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제